Article Information
History
- August 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Melissa C Kapulu1,2,*,
- Patricia Njuguna1,
- Mainga Hamaluba1,2,
- Domtila Kimani1,
- Joyce M. Ngoi1,
- Janet Musembi1,
- Omar Ngoto1,
- Edward Otieno1,
- Peter F Billingsley3,
- CHMI-SIKA Study Teama
- 1Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
- 2Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University Oxford, Oxford, UK
- 3Sanaria Inc., Rockville, MD, USA
- ↵*Corresponding author: Melissa C Kapulu mkapulu{at}kemri-wellcome.org
Posted August 11, 2020.
Naturally acquired immunity among Kenyan adults suppresses the West African P. falciparum NF54 strain in controlled human malaria infection (CHMI)
